Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1995-01-20
1996-11-26
Russel, Jeffrey E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
435194, 530329, A61K 3808, C07K 706, C12N 912
Patent
active
055785735
ABSTRACT:
The present invention provides viral integrase inhibiting peptides having the general structure, ##STR1## where Xaa is an amino acid or an amino acid analog, the stereochemistry of the amino acids or amino acid analogs can be D-amino acids or L-amino acids and the amino and carboxy termini of the peptide can be modified. The invention also provides viral inhibiting peptides having essentially the amino acid sequence, ##STR2## The invention also provides a pharmaceutical composition comprising a viral integrase inhibiting peptide and methods of using a viral integrase inhibiting peptide in vitro or in vivo to reduce or inhibit viral integrase activity in a cell and the infectivity of a virus.
REFERENCES:
patent: 5141735 (1992-08-01), Bellemin et al.
patent: 5413914 (1995-05-01), Franzusoff
Neuzil, Kathleen Maletic, "Pharmacologic Therapy for Human Immunodeficiency Virus Infection: A Review." Amer. J. Med. Sci. 307:368-373 (1994).
Cushman and Sherman, "Inhibition of HIV-1 Integration Protein by Aurintricarboxylic Acid Monomers, Monomer Analogs, and Polymer Fractions." Biomed. Biophy. Res. Comm. 185:85-90 (1992).
Fesen, Mark R. et al., "Inhibitors of Human Immunodeficiency Virus Integrase." Proc. Natl. Acad. Sci. USA 90:2399-2403 (1993).
Fesen, Mark R. et al., "Inhibition of HIV-1 Integrase by Flavones, Caffeic Acid Phenethly Ester (CAPE) and Related Compounds." Biomed. Pharm. 48:595-608 (1994).
Lafemina, Robert L. et al., "Inhibition of Human Immunodeficiency Virus Integrase by Bis-Chatechols." Antimicr. Agents. and Chemother. 39:320-324 (1995).
Mazumder, Abhijit et al., "Inhibition of Human Immunodeficiency Virus Type 1 Integrase by 3'-azido-3'-deoxythymidylate." Proc. Natl. Acad. Sci. USA 91:5771-5775 (1994).
Mazumder, Abhijit et al., "Inhibition of Human Immunodeficiency Virus Type 1 Integrase by a Hydrophobic Cation: The Phenanthroline-Cuprous Complex." Aids Res. and Human Retro. 11:115-125 (1995).
Houghten Richard A.
Plasterk Ronald H. A.
Puras Lutzke Ramon A.
Weber Patricia A.
Houghten Pharmaceuticals, Inc.
Russel Jeffrey E.
LandOfFree
Viral integrase inhibiting peptides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Viral integrase inhibiting peptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Viral integrase inhibiting peptides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1973175